Delta-9-tetrahydrocannabinolic acid A (THC-A) in urine of a 15-month-old child: A case report. 2018

Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, via Forlanini 12, 27100 Pavia, Italy. Electronic address: luca.morini@unipv.it.

BACKGROUND The acidic forms of cannabinoids, THC-A and CBD-A are naturally present in cannabis plants and preparations and are generally decarboxylated to the active compounds before the use (e.g. thermally decarboxylated through smoking). Hence, the identification of the acidic compounds in urine could be an evidence of cannabis ingestion rather than a passive exposure to smoke. This case report described a 15-month-old child that suffered an acute intoxication by accidental cannabis ingestion. It is important to assess the ingestion and to discriminate it from a passive exposure to better interpret the clinical findings and to establish the correct therapeutic procedure. METHODS Urine samples were simply diluted in deionized water and directly injected in the LC-MS/MS system. D3-THCCOOH was used as internal standard. Chromatographic separation of THCCOOH, THC-A and CBD-A was carried out in reversed phase on a c18 column. A triple quad in MRM negative mode was used to monitor the three analytes. CONCLUSIONS The developed LC-MS/MS method was simple and fast. A LOD of 3.0ng/mL and a LOQ of 10.0ng/mL were measured for the three compounds. The analytical procedure was validated accordingly to international guidelines. The two urine samples collected from the 15-month-old child at the hospitalization and after three days provided positive results for THCCOOH (130.0 and 10.0ng/mL respectively). THC-A was found only in the urine sample collected at the hospitalization (concentration: 70.0ng/mL). CONCLUSIONS THC-A was detected and quantitated in a urine sample of a 15-month-old child.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000061 Accidents, Home ACCIDENTS which occur within the home. Home Accidents,Accident, Home,Home Accident
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013759 Dronabinol A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. THC,Tetrahydrocannabinol,delta(9)-THC,9-ene-Tetrahydrocannabinol,Marinol,Tetrahydrocannabinol, (6a-trans)-Isomer,Tetrahydrocannabinol, (6aR-cis)-Isomer,Tetrahydrocannabinol, (6aS-cis)-Isomer,Tetrahydrocannabinol, Trans-(+-)-Isomer,Tetrahydrocannabinol, Trans-Isomer,delta(1)-THC,delta(1)-Tetrahydrocannabinol,delta(9)-Tetrahydrocannabinol,9 ene Tetrahydrocannabinol,Tetrahydrocannabinol, Trans Isomer

Related Publications

Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
January 2022, Archive of clinical cases,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
January 2023, Journal of clinical psychopharmacology,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
June 2024, Clinical case reports,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
August 2019, Paediatrics & child health,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
January 1998, Journal of analytical toxicology,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
March 2013, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
February 2023, Cannabis and cannabinoid research,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
February 1949, Clinical proceedings - Children's Hospital of the District of Columbia,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
July 2020, Medicine,
Luca Morini, and Jessica Quaiotti, and Matteo Moretti, and Antonio Marco Maria Osculati, and Luca Tajana, and Angelo Groppi, and Claudia Vignali
May 1975, The Journal of urology,
Copied contents to your clipboard!